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Supplementary methods 
Determination of the oligomeric state of Cmr 
Gel filtration was carried out using a calibrated Superdex column, equilibrated with 50 mM 
sodium phosphate buffer (pH 7.4) and 150 mM NaCl. Cmr samples (~1 mg ml-1) were 
treated with the indicated reagent before analysis and compared to a standard curve using 
proteins of known molecular mass. Crosslinking was carried out using purified Cmr (0.8 mg 
ml-1; 26.3 M monomer).  Samples were incubated for 60 min at 20°C with a 20-fold molar 
excess of dimethyl 3,3´-dithiobispropionimidate (DTBP) an imidoester cross-linker. DTBP 
was solubilized in 0.2 M triethanolamine buffer (pH 8.0) before the addition of Tris-HCl buffer 
pH 8.3 (final concentration 20 mM) to stop the reaction. Samples were then analyzed on 
SDS-PAGE (polyacrylamide gel electrophoresis). 
DNA fragments used in EMSAs 
Details of the DNA sequences used in the EMSAs reported here are provided below.  
Coding regions in black; non-coding regions in red, transcript starts in bold upper case 
(Pcmr, this work; PgroEL2, Stapleton et al., (1); others from Cortes et al., (2)), start codon for 
target gene underlined, start codon for divergent gene double underlined. 
1. PgroEL2 
375 bp fragment ligated into pCR4Blunt  TOPO – released by HindIII and XbaI from p2126 
gcggccgaccatttacgggtcttgttgtcgttggcggtcatgggccgaacatactcacccggatcgga
gggccgaggacacggtcgaacgaggggcatgacccggtgcggggcttcttgcactcggcataggcgag
tgctaagaataacgttgGcactcgcgaccggtgagtgctaggtcgggacggtgaggccaggcccgtcg
tcgcagcgagtggcagcgaggacaacttgagccgtccgtcgcgggcactgcgcccggccagcgtaagt
agcggggttgccgtcacccggtgacccccgtttcatccccgatccggaggaatcacttcgcaatggcc
aagacaattgcgtacgacgaagaggcccgtcgcg 
2. Pcmr 
230 bp fragment ligated into pGemTEasy  – released by EcoRI from pGS2462 
ccgccaagaatcggtttgtcagcgtgctgacagagtGcctggggcgcagaacgggcttgcgtgttctc
ttcgatcgactaatttcccattcAgggcaagccaacccgcacgcaatccacgcgcgctgacaattggc
agcacgatgacggcatcgcctgctctcaaggaggggccatggcagatcggtcggtgcgcccgctgcgg
catctcgttcatgcggtgactggggg 
3. Prv2007c 
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160 bp fragment ligated into pCR4Blunt  TOPO – released by HindIII and XbaI from p2365 
gagcgtgaatcccgctggcggtcgggtgaaccgccccggttttcttgcaccccgcgtcgacgtgccag
tgacgaacttgacgaataaggcctttggtcctttccggtaggggtctttggataggcgcgatcctcgg
catcgggccggtagcttgccgtTtgtg 
4. Prv2032 
201 bp fragment ligated into pCR4Blunt  TOPO – released by HindIII and XbaI from p2366 
tttgatgcctcctaatcgatggaaacggatgcctttgatccgaccagcccatcgtggccagggctagg
gacagaagtccccgaagcgcgggccatttgtccgcgcccgtcggtgatccacttggggaccattgacc
ctgttgtctgccaaccgccgttcagaaagatcggggtGatatcgaacagcggaggttgatcatgc 
5. Prv3133c 
428 bp fragment ligated into pCR4Blunt  TOPO – released by HindIII and XbaI from p2367 
cgcggaggtggacaatggtgtggtgctgcggcacgcattcgaggaggccaggctgcgcggagttccgc
tgcgggccgtggctgtccacgctgctgaaacacccgatgacgtcgaacagggcagccggttggcgcat
gtacacctgagccgtcggctcgcccactggacccggctctaccccgaggtgcgggtggatcgggccat
cgccggcggcagtgcgtgccgtcatctggccgccaacgcaaagccgggtcagctgttcgtcgcggact
cacactccgcgcacgaattgtgcggtgcataccagcccggatgcgccgtacttacggtacgcagtgcc
aacttgtagggagcggatCttgggagtggtgccctggtggtaaaggtcttcttggtcgatgaccacga
ggtggtgcgtcgtggtctgg 
6. Prv3134c 
584 bp fragment ligated into pCR4Blunt  TOPO – released by HindIII and XbaI from p2344 
tactccgcaggcccctaacgtcgattgcgcacccagcccaattcggacctcggtgtgggcatgcggga
gacggcagtggctccccccatggtcacgagcggctccgagtgggctccgctcgggcgcaggccggctg
atacttgttgaccagtgcggcaactcgtgccgcggccagtgtacaactgggcgggcaggttgtatggc
agtcgactgacggcggatcggagattgatcgacgccgtgccggccgcatcgagatgcgctctcacagc
gcggctatgcccaaatattctgtgggtcaagcgatatgcagccgatggacggccgctggttcggcagc
tgtcggcaactgtaagccatttctgggactttgctgtgaaaagctgggcgatggttgtggacctggac
gagccacccgtgcgataggtgagattcattctcgccctgacgggttgcgtctgtcatcggtcgataag
gactaacggccctcaggtggggaccaacgcccctgggagatagcggtccccgccagtaacgtaccgct
Gaaccgacgggatgtatccgccccagcgaaggagacggcgatg 
 
DNA fragments used as templates for in vitro transcription reactions 
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DNA sequences used in the in vitro transcription reactions are provided below. For the cmr 
templates the transcript starts (TSS1 and TSS2; Fig. 2E) are shown in bold font and the 
rv1676 transcript start is underlined. 
1. rrnAP3  
TAGAGCAATTCGAACGGGTATGCTGTTAGGCGACGGTCACCTATGGATATCTATGGATGACC
GAACCTGGTCTTGACTCCATTGCCGGATTTGTATTAGACTGGCAGGGTTGCCCCGAAGCGGG
CGGAAACAAGCAAGCGTGTTGTTTGAGAACTCAATAGTGTGTTTGGTGGTTTCACAGCAATT
CTCTA 
2. cmr-rv1676 (282 bp) 
TAGAGAATTCGTCCACCGGTTGATCGTTGATGTCCTGCAGACGGCGAGTCGGCACGGTCGCA
CCGCGGGCCAATCGAGTAGGCACCCCAATACCATACCGATGGCAAAACTCCGCCAAGAATCG
GTTTATTAGCGTGCTAATAGAGTGCCTGGGGCGCAGAACGGGCTTGCGTGTTCTCTTCGATC
GACTAATTTCCCATTCAGGGCAAGCCAACCCGCACGCAATCCACGCGCGCTGACAATTGGCA
GCACGATGACGGCATCGCCTGCTCGAATTCTCTA 
3. cmr-rv1676trunc1 (234 bp) 
GCACGGTCGCACCGCGGGCCAATCGAGTAGGCACCCCAATACCATACCGATGGCAAAACTCC
GCCAAGAATCGGTTTGTCAGCGTGCTGACAGAGTGCCTGGGGCGCAGAACGGGCTTGCGTGT
TCTCTTCGATCGACTAATTTCCCATTCAGGGCAAGCCAACCCGCACGCAATCCACGCGCGCT
GACAATTGGCAGCACGATGACGGCATCGCCTGCTCTCAAGGAGGGGCC 
4. cmr-rv1676trunc2 (171 bp) 
CCGCCAAGAATCGGTTTGTCAGCGTGCTGACAGAGTGCCTGGGGCGCAGAACGGGCTTGCGT
GTTCTCTTCGATCGACTAATTTCCCATTCAGGGCAAGCCAACCCGCACGCAATCCACGCGCG
CTGACAATTGGCAGCACGATGACGGCATCGCCTGCTCGAATTCTCTA 
 
Attempted reconstitution of Cmr with heme 
A 50 mM stock solution of hemin was prepared in 100 mM KOH and was used to prepare a 
working solution of 1 mM in 20 mM sodium phosphate, pH 7.4 containing 0.5 M NaCl.  The 
concentration of the solution was verified spectrophotometrically ( = 58400 M-1 cm-1 at 385 
nm).  A solution of Cmr (9.6 M) was titrated with hemin (0.5 M aliquots) and absorbance 
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spectra were recorded after 2 min incubation at 20°C.  As a control, the same concentration 
of the non-heme-binding protein CrpMt (Rv3676) was subjected to similar titrations.  
Quantitative-RT-PCR (qRT-PCR)   
RNA was isolated from 9 ml of early logarithmic phase (OD580 0.15-0.2) M. tuberculosis 
H37Rv cultures using the TRIZOL method (3). DNA contamination was removed using the 
TURBO DNA-free™ kit (Ambion, Life Technologies). After purification, total RNA was used 
for cDNA synthesis, using Superscript™ II Reverse Transcriptase (Invitrogen), according to 
the manufacturer’s instructions. qRTPCR was performed using primers specific for 16S 
rRNA gene, Myco16sF (5´-GAAACTGGGTCTAATACCG-3´) and Myco16sR (5´-
ATCTCAGTCCCAGTGTGG-3´) and cmr gene specific primers, RT1675F (5´-
AATCCGTGTCGCACAATCCA-3´) and RT1675R (5´-GTGACGATGTGTCGGCATTG-3´). 
qRT-PCR experiments were carried out in a Corbett Rotor Gene 6000 real time 
thermocycler, using a previously published protocol (4). Three technical replicates were 
performed for each experimental sample. Copy numbers of cmr transcripts per 1 g of RNA 
were calculated and normalised to 16S rRNA expression. 
  
7 
 
 
Supplementary Figures 
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Figure S1.  Cmr is dimeric. (A) Calibration curve for Superdex size exclusion chromatography 
equilibrated with 20 mM sodium phosphate, pH 7.4 containing 0.15 M NaCl.  Standards were: Blue 
dextran (200 kDa); hemoglobin (64.5 kDa); ovalbumin (43 kDa); cytochrome c (12.4 kDa); and 
aprotinin (6.5 kDa). (B) Elution profiles for Cmr as prepared (Protein, red trace), reduced 
(dithiothreitol, 1 mM, Protein DTT, blue trace), oxidized (diamide, 1 mM, Protein DA, green trace) and 
a threitol (1 mM) control (Protein DLT, purple trace).  All profiles were consistent with Cmr eluting as a 
dimer (~70 kDa).  (C) Chemical cross-linking of Cmr with dimethyl 3,3´-dithiobispropionimidate 
(DTBP).  Separation by SDS-PAGE (denaturing) showed the presence of species of molecular weight 
~30 kDa, equivalent to uncross-linked Cmr monomer and ~60 kDa, equivalent to a cross-linked Cmr 
dimer.  The samples shown are aliquots of Cmr (0.8 mg ml
-1
) without treatment, after 60 min 
incubation with a 20-fold molar excess of DTBP (Cmr plus X-linker). 
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Figure S2: Identification of cmr transcript starts in vivo and in vitro and the effect of cAMP on 
transcription in vitro.  (A) Artemis traces showing two transcript start sites (arrowed, TSS) upstream 
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of the cmr (rv1675c) coding region (2).  The red line indicates the transcription in the reverse direction 
and the blue line for the forward direction.  The lower panel shows the DNA and amino acid 
sequences for this region.  The initial Met (M) of Cmr is highlighted in pale blue on the left and the 
beginning of the Rv1676 open reading frame is similarly highlighted on the right.   (B) Identification of 
the Cmr-activated rv1676 transcript.  The diagram (not to scale) show the different templates used in 
the transcription reactions.  The black arrows indicate the cmr transcript starts; the grey arrow 
indicates the rv1676 transcript start; the black rectangle indicates the Cmr binding site. Upper 
autoradiograph: Different fragments of DNA containing the rv1675c-rv1676 intergenic region were 
incubated with M. smegmatis RNA polymerase in the presence of 5 nM (left lanes marked 282, 234 
and 171) or 1 nM (right lanes marked 282, 234 and 171) Cmr protein; the numbers indicate the length 
of the DNA templates used shown diagrammatically above the autoradiographs.  The sequences of 
the DNA templates used are provided in Supplementary methods section (see above).  Based on the 
data shown in Fig. 2E, the 282 bp, 234 bp and 171 bp templates in the presence of Cmr should all 
yield the cmr transcript of ~80 bases.  The rv1676 transcript should be present (~80 bases) when the 
282 bp template is used, but would be undetectable (37 bases and absent) for the shorter templates.  
Thus, using templates with shorter DNA sequences downstream of the rv1676 transcript start it was 
possible to assign the Cmr-activated cmr transcript.  Transcription reactions were carried out as 
described in the Materials and Methods.  The cmr (TSS2) and rv1676 transcripts are indicated.  
Transcripts of know sizes (280 bases and 190 bases) are shown in the outermost lanes of the middle 
autoradiograph to calibrate the gel. Lower autoradiograph: in this experiment the different DNA 
templates were subject to in vitro transcription in the presence of increasing concentrations of Cmr as 
indicated above each lane.  (C) Cyclic AMP does not alter Cmr-regulated transcription from the cmr-
rv1676 intergenic region in in vitro transcription reactions.  The locations of transcripts assigned to 
cmr (TSS1 and TSS2) and rv1676 are indicated.   
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(A) 
tgggcgatggttgtggacctggacgagccacccgtgcgataggtgagattcat
tctcgccctgacgggttgcgtctGTCAtCggtCgataaggactaacggccctc
aggtggggaccaacgcccctgggagatagcgGTCccCgccaGtaacgtaccgc
tgaaccgacgggatgtatccgccccagcgaaggagacggcgATG 
 
(B) 
accccgaggtgcgggtggatcgggccatcgccggcggcagtgcgtgccGTCAt
CtgGccgcCaacgcaaagccggGTCAGCtgttcGtCgcggactcacactccgc
gcacgaattgtgcggtgcataccagcccggatgcgccgtacttacggtacgca
gtgccaacttgtagggagcggatcttgggagtggtgccctgGTG 
Figure S3: DNA sequences upstream of the rv3134c and rv3133c (dosR) open reading frames.  
DNA sequences (200 bp) upstream of (A) the rv3134c open reading frame (ATG start codon) and (B) 
the rv3133c open reading frame (GTG start codon).  Potential Cmr binding sites are indicated in bold 
type face with bases that match the consensus sequence (GTCAGCnnGTGAC; identified by ChIP-
seq analyses and confirmed by mutation of this site at the cmr promoter) shown in upper case.  The 
start codons are shown in upper case and the transcript start sites are underlined (2).     
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Figure S4.  Replacement of Cmr Cys residues enhances DNA-binding under non-reducing 
conditions.  Cmr variants with either one or both Cys residues replaced by Ala were created by site-
directed mutagenesis.  The corresponding proteins were incubated with radiolabelled cmr-rv1676 
intergenic region DNA (Pcmr) without (as prepared) or with dithiothreitol (plus 5 mM DTT) and the 
protein-DNA complexes (C) formed were separated by electrophoresis and visualized by 
autoradiography.  The final concentrations of the indicated Cmr proteins used in the EMSA are 
indicated above the gel images.   
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Figure S5.  Expression of cmr in the parent and complemented cmr mutant strains of M. 
tuberculosis.  Total RNA was isolated from early logarithmic phase (OD580 0.15-0.2) M. tuberculosis 
H37Rv cultures (wild-type and complemented cmr mutant) and cmr cDNA was synthesized as 
described in Supplementary methods.  Copy numbers of cmr transcripts per 1 g of RNA were 
calculated and normalized to 16S rRNA expression (the mean values and standard deviations are 
shown).  The data suggest a 2.2-fold increase in expression of cmr in the complemented mutant 
compared to the wild-type strain. 
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Supplementary Tables  
Table S1: List of strains and plasmids used in this study. 
Strain Relevant characteristics Source or Reference 
BL21 (DE3) Escherichia coli BL21 (DE3) lysogen 
carrying a copy of the T7 RNA 
polymerase under the control of the IPTG-
inducible lacUV5 promoter 
Novagen 
JRG2357 DH5ɑ ΔlacZYA-argF, lacZΔM15 Invitrogen 
Mycobacterium smegmatis mc2 155 RNAP production (5) 
Mycobacterium tuberculosis H37Rv Wild-type virulent strain Lab strain 
Mycobacterium tuberculosis Δcmr Deletion mutant of cmr This work 
Mycobacterium tuberculosis cmr 
complement 
M. tuberculosis Δcmr/cmr This work 
Plasmid Relevant characteristics Source or Reference 
pGS2103 pET28a-cmr; KanR This work 
p2126 pCR4Blunt-TOPO-PgroEL2; KanR and D. M. Hunt, NIMR 
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AmpR 
p2365 pCR4Blunt-TOPO-Prv2007c; KanR D. M. Hunt, NIMR 
p2366 pCR4Blunt-TOPO-Prv2032; KanR D. M. Hunt, NIMR 
p2367 pCR4Blunt-TOPO-Prv3133c; KanR D. M. Hunt, NIMR 
p2344 pCR4Blunt-TOPO-Prv3134c; KanR D. M. Hunt, NIMR 
pGS2462 pGEM-tEASY-Pcmr This work 
pGS2531 pGEM-tEASY-Pcmr with altered bases in 
the palindromic binding site  
This work 
M. tuberculosis shuttle plasmids Relevant characteristics Source or Reference 
p2NIL Suicide gene delivery vector, oriE, kan T. Parish (6) 
pGOAL17 Phsp60–sacB, PAg85a 
–lacZ marker gene cassette, amp, oriE 
T. Parish (6) 
P2NIL:1675c.17 Delivery plasmid for deletion of cmr gene; 
KanR 
This work 
pKP186 Integrase-negative derivative of the 
integrating vector pMV306 
K.G. Papavinasasundaram 
(unpublished) 
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pBS-int Integrase-positive plasmid lacking a M. 
tuberculosis origin of replication 
B. Springer (unpublished) 
 
* AmpR, ampicillin resistant; KanR, kanamycin resistant 
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Table S3.  Comparison of the genome sequences of the M. tuberculosis H37Rv (parent) and the M. tuberculosis H37Rv cmr deletion 
(mutant) strain. 
Strain Gene Comment  Reference 
Mutant fadE6, rv0271 SNP: P7L, the first residue in the domain acyl-CoA-dehydrogenase domain; non-essential for 
growth; pseudogene in M. leprae  
(7-9) 
Mutant  rv0796 Deleted (14 bp remaining); transposase; deleted in clinical isolates (10) 
Mutant rv1130, prpD SNP: R9P; the same SNP is found in M. tuberculosis BTB04-172 (monoisolate); R9H in M. 
tuberculosis TKK-01-0058  
Erdman prpDC mutant is unable to grow on propionate; growth is severely impaired in non-
activated murine bone marrow-derived macrophages; growth and persistence in the lung and 
spleen is comparable to wild-type; absent in M. leprae  
(7,8, This work)  
Mutant rv1675c, cmr Deleted (12 bp remaining) This work 
Parent rv1960, parD1 SNP: R51G; ParD antitotxin; non-essential for growth; absent in M. leprae; SNPs were found 
in M. tuberculosis strains: M1V; A78P; G82A 
(7,8, This work) 
Mutant rv2323, dhaH SNP: L202P; multiple SNPs in M. tuberculosis strains, R30H; V72I, A120T, H201Y, T213A; S222N;  
non-essential amidinotransferase; pseudogene in M. leprae  
(7,8, This work)  
Parent rv2962 SNP: T234I; other SNP in database H233Q; in M. leprae T234Q; non-essential uridine 5'- (7,8)  
19 
 
diphospho-glucuronosyltransferase 
Mutant rv2984, ppk1 SNP: Q476R in phospholipase domain; essential for in vitro growth; impaired stress survival; 
down-regulation results in impaired survival in macrophages 
(7,8,11)  
Mutant rv3184 Deleted (12 bp remaining); transposase; deleted in clinical isolates (7,8,10)  
Mutant rv3185 Deleted (0 bp remaining); transposase; deleted in clinical isolates (7,8,10) 
Mutant rv3326 Deleted (8 bp remaining); transposase  (7)  
Mutant rv3331, sugI SNP: P423T; other SNP in database P423L (most strains); non-essential sugar transporter; 
pseudogene in M. leprae  
(7,8)  
Parent rv2931, pspA SNP: E419K; Phenolpthiocerol synthesis type-I polyketide synthase; non-essential for growth; 
present in M. leprae; multiple SNPs in M. tuberculosis strains: G549S, A803T, V862I, R877H, 
H955P 
(7,12)  
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